Complete Genomics said this week that it will offer customers of its research whole-genome sequencing service access to Ingenuity's variant analysis capabilities.
Complete Genomics said that all orders for new research genomes will now include access to Ingenuity Variant Analysis for six months. The bundled offering will provide customers with a complete workflow to analyze, interpret, and prioritize biologically relevant genetic variations, the company said.
Ingenuity Variant Analysis, launched earlier this year, uses Ingenuity's database of curated biological data and mutation information to help researchers filter millions of variants in sequencing data sets to identify causal variants based on known relationships with pathways, genes, biological processes, and diseases (BI 1/13/2012).
As part of the agreement, customers who use Ingenuity Variant Analysis will receive access to a control dataset from the Wellderly study — a collaborative project between Complete Genomics and the Scripps Health System (BI 11/7/2011).
Financial details of this agreement were not disclosed.